Prime Medicine (PRME) Other Non Operating Income (2021 - 2026)

Prime Medicine (PRME) has 6 years of Other Non Operating Income data on file, last reported at $51000.0 in Q1 2026.

• Quarterly Other Non Operating Income rose 37.84% year-over-year to $51000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $162000.0 (up 350.0% YoY) and the FY2025 annual result came in at $148000.0, up 260.98% from the prior year.
• Other Non Operating Income grew to $51000.0 in Q1 2026, from $49000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.1 million in Q1 2023 to a low of -$83000.0 in Q3 2024.
• A 5-year average of $265294.1 and a median of $43000.0 in 2023 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income soared 72900.0% — and 2024, when it tumbled 293.02%.
• Tracing PRME's Other Non Operating Income over 5 years: stood at $926000.0 in 2022, then plunged by 84.02% to $148000.0 in 2023, then sank by 70.95% to $43000.0 in 2024, then grew by 13.95% to $49000.0 in 2025, then advanced by 4.08% to $51000.0 in 2026.
• The last three Other Non Operating Income figures came in at $51000.0 (Q1 2026), $49000.0 (Q4 2025), and $44000.0 (Q3 2025), per Business Quant data.